Breaking News Instant updates and real-time market news.

IMPV

Imperva

$46.65

0.65 (1.41%)

17:05
02/15/18
02/15
17:05
02/15/18
17:05

Imperva Chief Revenue Officer Mike Mooney resigns

Imperva announced that its Chief Revenue Officer, Mike Mooney, has decided to resign in order to pursue other interests. Mr. Mooney will remain with Imperva through February 23, 2018. The company has retained Heidrick & Struggles, a leading executive search firm, to assist in recruiting a permanent CRO.

  • 26

    Feb

  • 27

    Feb

  • 14

    Mar

IMPV Imperva
$46.65

0.65 (1.41%)

02/09/18
IMPC
02/09/18
NO CHANGE
IMPC
Imperva price target raised to $55 from $50 at Imperial Capital
Imperial Capital analyst Diane Sievert maintained an Outperform rating on Imperva and raised her price target to $55 from $50, saying Imperva is making early turnaround progress under its new leadership, and highlighting the expansion in the amount of large transactions in Q4 and the continued strong subscription growth.
02/09/18
PIPR
02/09/18
UPGRADE
Target $52
PIPR
Overweight
Imperva upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Andrew Nowinsk upgraded Imperva to Overweight and raised his price target for the shares to $52 from $42. The analyst views the company's fiscal 2018 outlook as "too conservative" and believes it is well positioned to exceed it. Imperva's products are still "highly strategic," and its subscriptions are growing 30%-plus year-over-year, Nowinsk tells investors in a post-earnings research note.
01/26/18
JMPS
01/26/18
NO CHANGE
JMPS
Fortinet, Proofpoint targets raised after positive checks at JMP Securities
JMP Securities analyst Erik Suppiger said his industry discussions lead him to believe the cyber-security spending environment has been relatively healthy and that security remains top of mind for enterprise buyers. Demand for internal security technologies that monitor and detect intrusions or technologies that add additional layers of security for specific assets is benefiting vendors such as CyberArk Software (CYBR), Proofpoint (PFPT), and Imperva (IMPV), Suppiger said. Given his positive channel checks and an appreciation in valuation multiples, Suppiger raised his price target on Proofpoint to $115 from $95 and on Fortinet (FTNT) to $54 from $41.
12/12/17
12/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Juno Therapeutics (JUNO) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Jim Birchenough saying that while data for JCAR017 continue to support a potential best-in-class profile in aggressive lymphoma, the current valuation already reflects dominant market positioning over Gilead's (GILD) Yescarta. 2. General Dynamics (GD) downgraded to Underweight from Neutral at JPMorgan, with analyst Seth Seifman saying Gulfstream questions are unlikely to be resolved in the near term. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst said. Seifman also downgraded Raytheon (RTN) to Neutral from Underweight. 3. Adobe (ADBE), Barracuda (CUDA), GoDaddy (GDDY), Fortinet (FTNT) and Check Point (CHKP) downgraded to Neutral from Overweight and CoStar Group (CSGP), Imperva (IMPV) and Monotype Imaging (TYPE) downgraded to Underweight from Overweight at JPMorgan by analyst Sterling Auty in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. 4. Spark Therapeutics (ONCE) downgraded to Neutral from Buy at UBS, with analyst Carter Gould seeing a "challenging setup" for the shares after the Phase 1/2 SPK-8011 data in hemophilia A fell short of expectations. The analyst removed SPK-8011, or $29 per share, and early-stage pipeline value, or $12 per share, from his model. He finds it difficult to be more constructive on Spark shares in the near-term. 5. Electronic Arts (EA) downgraded to Buy from Conviction Buy at Goldman Sachs by analyst Christopher Merwin to reflect fewer near-term catalysts around in-game monetization of non-sports titles. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CIEN

Ciena

$34.90

2.765 (8.60%)

07:04
12/14/18
12/14
07:04
12/14/18
07:04
Recommendations
Ciena analyst commentary  »

Ciena price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTX

Leap Therapeutics

$2.85

-0.27 (-8.65%)

07:03
12/14/18
12/14
07:03
12/14/18
07:03
Hot Stocks
Leap Therapeutics presents TRX518 data at ESMO »

Leap Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$139.16

-4.28 (-2.98%)

07:03
12/14/18
12/14
07:03
12/14/18
07:03
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
12/14/18
12/14
07:02
12/14/18
07:02
General news
Futures lower after underwhelming Chinese data »

Stock futures are…

BCEI

Bonanza Creek

$25.01

-0.26 (-1.03%)

07:02
12/14/18
12/14
07:02
12/14/18
07:02
Initiation
Bonanza Creek initiated  »

Bonanza Creek initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.90

0.8 (1.21%)

07:00
12/14/18
12/14
07:00
12/14/18
07:00
Recommendations
Starbucks analyst commentary  »

Starbucks can sustain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

07:00
12/14/18
12/14
07:00
12/14/18
07:00
General news
FX Update: The dollar has traded firmer »

FX Update: The dollar has…

TCBI

Texas Capital

$53.03

-2.42 (-4.36%)

06:57
12/14/18
12/14
06:57
12/14/18
06:57
Initiation
Texas Capital initiated  »

Texas Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

GCO

Genesco

$42.10

-2.39 (-5.37%)

06:57
12/14/18
12/14
06:57
12/14/18
06:57
Hot Stocks
Genesco increases stock repurchase program to $125M »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAMN

Kaman

$56.89

-0.18 (-0.32%)

06:55
12/14/18
12/14
06:55
12/14/18
06:55
Downgrade
Kaman rating change  »

Kaman downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GCO

Genesco

$42.10

-2.39 (-5.37%)

06:55
12/14/18
12/14
06:55
12/14/18
06:55
Hot Stocks
Genesco to sell Lids Sports Group for $100M to FanzzLids Holdings »

Genesco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:55
12/14/18
12/14
06:55
12/14/18
06:55
General news
Oil action: Front-month WTI crude prices are down 0.7% »

Oil action: Front-month…

WEI

Weidai

$10.00

-0.14 (-1.38%)

06:52
12/14/18
12/14
06:52
12/14/18
06:52
Initiation
Weidai initiated  »

Weidai initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$256.24

-2.055 (-0.80%)

06:51
12/14/18
12/14
06:51
12/14/18
06:51
Hot Stocks
NeoTract: 12-month results from study of UroLift System published »

NeoTract, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.87

0.51 (0.45%)

06:51
12/14/18
12/14
06:51
12/14/18
06:51
Hot Stocks
Eli Lilly expands collaboration with Evidation Health for Andromeda platform »

Eli Lilly and Evidation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

SBUX

Starbucks

$66.90

0.8 (1.21%)

06:50
12/14/18
12/14
06:50
12/14/18
06:50
Recommendations
Starbucks analyst commentary  »

Starbucks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DEA

Easterly Government Properties

$17.41

0.03 (0.17%)

06:50
12/14/18
12/14
06:50
12/14/18
06:50
Upgrade
Easterly Government Properties rating change  »

Easterly Government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$78.44

0.95 (1.23%)

06:47
12/14/18
12/14
06:47
12/14/18
06:47
Hot Stocks
Merck to acquire Antelliq Group for approximately EUR2.1B »

Merck and privately held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 16

    Feb

SBUX

Starbucks

$66.90

0.8 (1.21%)

06:46
12/14/18
12/14
06:46
12/14/18
06:46
Recommendations
Starbucks analyst commentary  »

Starbucks' LT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

MRK

Merck

$78.44

0.95 (1.23%)

06:45
12/14/18
12/14
06:45
12/14/18
06:45
Hot Stocks
Breaking Hot Stocks news story on Merck »

Merck to acquire Antelliq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 16

    Feb

LSCC

Lattice Semiconductor

$6.63

-0.05 (-0.75%)

06:45
12/14/18
12/14
06:45
12/14/18
06:45
Upgrade
Lattice Semiconductor rating change  »

Baird upgrades Lattice to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$21.35

0.11 (0.52%)

06:44
12/14/18
12/14
06:44
12/14/18
06:44
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$247.71

2.27 (0.92%)

06:43
12/14/18
12/14
06:43
12/14/18
06:43
Recommendations
Adobe analyst commentary  »

Adobe price target cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$56.60

0.09 (0.16%)

06:41
12/14/18
12/14
06:41
12/14/18
06:41
Recommendations
Carnival analyst commentary  »

Nomura sees 30% total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 20

    Dec

DLTR

Dollar Tree

$85.04

0.45 (0.53%)

06:38
12/14/18
12/14
06:38
12/14/18
06:38
Upgrade
Dollar Tree rating change  »

Dollar Tree upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.